As COVID-19 continues to ravage the economy, the federal government is taking action to bring relief to businesses, as they work to navigate this unprecedented crisis.
The COVID-19 pandemic has adversely impacted vulnerable populations, particularly individuals with opioid use disorder (OUD). Individuals with OUD are more likely to experience homelessness or incarceration and may be at increased risk of exposure to COVID-19.
With the spread of COVID-19 accelerating across the country, most healthcare organizations are in uncharted territory in terms of how to respond.
Fourteen states—including, for the first time, California and Texas, the two most populous states—will hold a presidential primary on Super Tuesday.
Discover the Latest Social Determinants of Health Trends, Strategies and Opportunities.
In October 2019, the Department of Health and Human Services (HHS) released two proposed rules that include some of the most significant changes in at least a decade to the regulations governing fraud and abuse in federal healthcare programs, including Medicare and Medicaid.
Discover the key lessons learned from the Massachusetts, Oregon and other state benchmarking models. Click here to view the webinar free on demand, and download free copies of the presentation and companion white paper.
The 340B drug discount program continues to expand, with the number of participating covered entities almost doubling in the past five years to 38,000, according to the Government Accountability Office.
The average cost of a Telephone Consumer Protection Act (TCPA) settlement is estimated at $6.6 million—and healthcare is among the top three industries being targeted for TCPA litigation.
Healthcare providers are increasingly deploying telehealth capabilities that will extend services to patients in rural areas, provide high-quality care to individuals with complex conditions and reduce costs associated with unnecessary emergency department usage.